Terumo has completed its previously announced purchase of OrganOx for nearly $1.5bn after meeting all necessary regulatory ...
Elucid has launched PlaqueIQ, an AI-based image analysis software that quantifies plaque build-up to evaluate a patient’s ...
Roche has obtained CE mark approval for its fully automated immunoassay, Elecsys Dengue Ag test, intended for diagnosing ...
EndoQuest Robotics is collaborating with NVIDIA to integrate protocols within its endoluminal robotic surgery technology as ...
Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...
VentureMed has raised $28m to accelerate the commercial adoption and expand indications for its FLEX Vessel Preparation (FLEX ...
The FDA has granted breakthrough device designation to Augurex’s SPINEstat 14-3-3eta Autoantibody Multiplex Immunoassay Test.
South Korea-based MOPIC has introduced an autostereoscopic 3D display aimed at endoscopic and microscope imaging applications ...
GE HealthCare has raised its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid solid demand ...
Co-Dx has signed a definitive agreement with Arabian Eagle Manufacturing to create a joint venture (JV) for PCR platform ...
A sales probe from Organon's board has found evidence of wholesaler sales malpractice, resulting in Ali's resignation and a ...
As healthcare systems increasingly turn to personalised approaches, Belgian company Materialise is accelerating efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results